Coronavirus 2019-2020 thread (no unsubstantiated rumours!)

D

dratsabknihcllik

Junior Member
Registered Member
localizer said:
https://twitter.com/i/web/status/1249664403026280449
:eek: :oops:
Click to expand...
What a pity! Look a squirrel!

India should have banned Deutsche welle just as China banned nyt or wapo. In this aspect I believe being open minded and accomodating have caused Indian and her people a tremendous fortune.

On a serious note: no need to be so defensive and try to find the misery of Indian daily wage earners because of a pandemic which was caused by a certain country that is scrambling to prove its innocence. India is a poor country and nobody denies it. The question is, can India expect that the civilized world take any action against the repeat offender.
The jury is still out.
 
vesicles

vesicles

Colonel
Jura said:
do you consider to be promising some of Yesterday at 12:05 PM

specifically?
Click to expand...

I'm not a virologist. So I don't know the specifics of any of these candidates. However, the ones moved to clinical trials should obviously be the most promising.

Of all the candidates, the live/attenuated and inactivated viruses would be the most traditional ones. I actually am more hopeful of these.

Of the newer techs established in the field of oncology, I would be more cautious. In terms of immunal therapy, the field of oncology is very different than a viral infection. Because cancer is a terminal illness and has very few effective treatment options, we have much less strict requirements for a cancer-treating immunal therapy. Usually, if you can show that one patient (yes, that's not a typo. A single patient data is enough) gets better with the treatment, that's good enough for everyone to agree to continue. Because cancer patients face almost certain death, any option is better than not doing anything... Even if that means severe side effects (shortening your life by 10-20 years), because being able to live an extra week becomes a luxury for these patients. That's why oncology usually has lower standards for drug safety. On the other hand, the standards for a coronavirus infection that kills only 4% of the infected should be so much higher. So I would say the strategies that work in oncology may not work in COVID-19. Let's see what happens...
 
You must log in or register to reply here.
Top